Pharmafile Logo
Pharmafocus logo
Advanced Search

COVID-19

Showing 15 posts of 602 posts found.

who_flag

WHO backs AstraZeneca vaccine against South African variant

February 9, 2021
Manufacturing and Production COVID-19, WHO, vaccines

World health officials have moved to ease concerns over the efficacy of the Oxford University-AstraZeneca vaccine against new variants of …

News
uk_gov

CureVac enters collaboration with UK government on coronavirus variant vaccines

February 8, 2021
Sales and Marketing COVID-19, CureVac

CureVac has entered a collaboration with the UK government to develop and manufacture potential vaccine candidates against coronavirus variants, with …

News
astrazeneca_building_white

South Africa halts rollout of AstraZeneca’s COVID-19 vaccine amid efficacy concerns

February 8, 2021
Sales and Marketing AstraZeneca, COVID-19

AstraZeneca is racing to adapt its COVID-19 vaccine as new data suggests it offers little protection against the more dominant …

News
image_readtop_2018_569751_15365546683454581

South Korea approves Celltrion’s COVID-19 treatment Regdanvimab for emergency use

February 8, 2021
Sales and Marketing COVID-19, celltrion

The South Korean Ministry of Food and Drug Safety (MFDS) has granted a conditional marketing authorisation (CMA) for the emergency …

News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

February 5, 2021
Medical Communications COVID-19

In the last week, a number of COVID-19 vaccine developments have been made. Johnson & Johnson’s one-shot jab was found …

News
astrazeneca-sign

New Oxford University-AstraZeneca vaccine against COVID-19 mutations could be available by October

February 5, 2021
Medical Communications AstraZeneca, COVID-19

Oxford University and AstraZeneca could release a new vaccine by October in order to counter the new mutations of COVID-19 …

News
pfizer_building_logo1

Pfizer withdraws application for emergency vaccine authorisation in India

February 5, 2021
Medical Communications COVID-19, Pfizer

Pfizer has withdrawn its application in India for emergency use authorisation of its vaccine, which it has produced with German …

News
covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

February 3, 2021
Research and Development COVID-19

The past week has seen mostly positive COVID-19 vaccine developments; Pfizer has confirmed its jab is effective against both the …

News
astrazeneca_sign_sky

Longer Oxford-AstraZeneca vaccine interval improves efficacy, report says

February 3, 2021
Research and Development AstraZeneca, COVID-19

A longer interval between doses of the Oxford University-AstraZeneca vaccine could substantially improve efficacy, according to a report published in …

News

GSK and CureVac sign £132m deal to develop next-generation COVID-19 vaccine

February 3, 2021
Research and Development COVID-19, CureVac, GlaxoSmithKline

GlaxoSmithKline (GSK) and CureVac have today announced they are joining forces to develop a new COVID-19 vaccine to combat future …

News

Johnson & Johnson’s single-shot COVID-19 vaccine 85% effective

February 1, 2021
Sales and Marketing COVID-19, Johnson & Johnson, vaccines

Johnson & Johnson has announced that its COVID-19 vaccine candidate is 85% effective in preventing serious symptoms of the disease, …

News
astrazeneca-sign

AstraZeneca COVID-19 vaccine not for over 65s, German health body says

January 29, 2021
Medical Communications AstraZeneca, COVID-19

Germany’s main public health body has recommended that AstraZeneca’s COVID-19 vaccine is only administered to those aged between 18 and …

News
novavax

Novavax COVID-19 vaccine shows almost 90% efficacy in Phase III trial

January 29, 2021
Medical Communications COVID-19, Novavax

Novavax has announced that its COVID-19 vaccine candidate, NVX-CoV2373, demonstrated an efficacy of 89.3% in its UK Phase III trial. …

News
valneva

Valneva begins production of its COVID-19 vaccine

January 28, 2021
COVID-19, Valneva

Valneva, a specialty vaccine company focused on the prevention of infectious diseases with significant unmet medical needs, has commenced production …

News
astrazeneca_building_white

AstraZeneca rejects “incorrect” claims about COVID-19 vaccine efficacy

January 26, 2021
Manufacturing and Production AstraZeneca, COVID-19

AstraZeneca has rejected claims by German media that its COVID-19 vaccine has only 8% efficacy in over-65s. Two German newspapers, …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025